97 related articles for article (PubMed ID: 25684506)
1. Elevated fasting blood glucose is associated with increased risk of breast cancer: outcome of case-control study conducted in Karachi, Pakistan.
Haseen SD; Khanam A; Sultan N; Idrees F; Akhtar N; Imtiaz F
Asian Pac J Cancer Prev; 2015; 16(2):675-8. PubMed ID: 25684506
[TBL] [Abstract][Full Text] [Related]
2. Fasting glucose is a risk factor for breast cancer: a prospective study.
Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
[TBL] [Abstract][Full Text] [Related]
3. Status of serum adiponectin related to insulin resistance in prediabetics.
Ahsan S; Ahmed S; Ahmed SD; Nauman K
J Pak Med Assoc; 2014 Feb; 64(2):184-8. PubMed ID: 24640810
[TBL] [Abstract][Full Text] [Related]
4. Serum Adiponectin Level Association with Breast Cancer Risk: Evidence from a Case-Control Study.
Ahmed SD; Khanam A; Sultan N; Idrees F; Akhter N
Asian Pac J Cancer Prev; 2015; 16(12):4945-8. PubMed ID: 26163619
[TBL] [Abstract][Full Text] [Related]
5. Roles of adiposity, lifetime physical activity and serum adiponectin in occurrence of breast cancer among Malaysian women in Klang Valley.
Shahar S; Salleh RM; Ghazali AR; Koon PB; Mohamud WN
Asian Pac J Cancer Prev; 2010; 11(1):61-6. PubMed ID: 20593932
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression.
Ferroni P; Riondino S; Laudisi A; Portarena I; Formica V; Alessandroni J; D'Alessandro R; Orlandi A; Costarelli L; Cavaliere F; Guadagni F; Roselli M
Oncologist; 2016 Sep; 21(9):1041-9. PubMed ID: 27388232
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk in metabolically healthy but overweight postmenopausal women.
Gunter MJ; Xie X; Xue X; Kabat GC; Rohan TE; Wassertheil-Smoller S; Ho GY; Wylie-Rosett J; Greco T; Yu H; Beasley J; Strickler HD
Cancer Res; 2015 Jan; 75(2):270-4. PubMed ID: 25593034
[TBL] [Abstract][Full Text] [Related]
10. Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer.
Kabat GC; Kim M; Caan BJ; Chlebowski RT; Gunter MJ; Ho GY; Rodriguez BL; Shikany JM; Strickler HD; Vitolins MZ; Rohan TE
Int J Cancer; 2009 Dec; 125(11):2704-10. PubMed ID: 19588485
[TBL] [Abstract][Full Text] [Related]
11. Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study.
Minatoya M; Kutomi G; Shima H; Asakura S; Otokozawa S; Ohnishi H; Akasaka H; Miura T; Mori M; Hirata K
Asian Pac J Cancer Prev; 2014; 15(19):8325-30. PubMed ID: 25339024
[TBL] [Abstract][Full Text] [Related]
12. Low Prevalence of Insulin Resistance Among Iranian Patients with Chronic Hepatitis C Virus Infection: A Case-Control Study.
Eshraghian K; Lankarani KB; Fattahi MR; Esmailnejad A; Peymani P
Curr Diabetes Rev; 2018; 14(5):446-450. PubMed ID: 28714382
[TBL] [Abstract][Full Text] [Related]
13. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
Hussein MS; Abushady MM; Refaat S; Ibrahim R
Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
[TBL] [Abstract][Full Text] [Related]
14. [Change and correlated factors of fasting level of the plasma endotoxin in subjects with different glucose tolerances and body mass indices].
Liu YH; Zhao TY; Hou LQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):769-73, 778. PubMed ID: 24325109
[TBL] [Abstract][Full Text] [Related]
15. Risk association of fasting insulin resistance index in non-diabetic heart failure patients: A case-control study at Karachi, Pakistan.
Ahsan M; Azmi MB; Ahmed SDH; Khan AA; Mudassir HA
Pak J Pharm Sci; 2021 Mar; 34(2):567-575. PubMed ID: 34275831
[TBL] [Abstract][Full Text] [Related]
16. The effect of insulin resistance on breast cancer risk in Latinas of Mexican origin.
Cordero-Franco HF; Salinas-Martínez AM; Abundis A; Espinosa-Flores EM; Vázquez-Lara J; Guerrero-Romero F
Metab Syndr Relat Disord; 2014 Nov; 12(9):477-83. PubMed ID: 25136964
[TBL] [Abstract][Full Text] [Related]
17. Effect of HCV on fasting glucose, fasting insulin and peripheral insulin resistance in first 5 years of infection.
Ahmed N; Rashid A; Naveed AK; Bashir Q
J Pak Med Assoc; 2016 Feb; 66(2):140-2. PubMed ID: 26819155
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and hypertension in postmenopausal women.
Feldstein CA; Akopian M; Renauld A; Olivieri AO; Cauterucci S; Garrido D
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S145-50. PubMed ID: 11986914
[TBL] [Abstract][Full Text] [Related]
19. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study.
Song Y; Manson JE; Tinker L; Howard BV; Kuller LH; Nathan L; Rifai N; Liu S
Diabetes Care; 2007 Jul; 30(7):1747-52. PubMed ID: 17468352
[TBL] [Abstract][Full Text] [Related]
20. Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study.
Contiero P; Berrino F; Tagliabue G; Mastroianni A; Di Mauro MG; Fabiano S; Annulli M; Muti P
Breast Cancer Res Treat; 2013 Apr; 138(3):951-9. PubMed ID: 23568483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
